Selzentry® (maraviroc) – Expanded indication
October 30, 2020 - The FDA approved ViiV Healthcare’s Selzentry (maraviroc), in combination with other antiretroviral agents for the treatment of only CCR5-tropic human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing at least 2 kg.
Top